Ex-Pfizer R&D head Dr David Roblin joins Destiny Pharma
November 7, 2011Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Destiny Pharma, Pfizer, R&D
Anti-microbial drug developers Destiny Pharma have appointed Dr David Roblin as its new medical director. Dr Roblin was formerly head …
Aslan licences promising cancer drug from Bristol-Myers Squibb
November 7, 2011Research and Development, Sales and Marketing Aslan, BMS, Cancer
Bristol-Myers Squibb has licensed one of its investigational oncology compounds, for the treatment of multiple solid tumours, to Singapore-based Aslan …
Xarelto gains lucrative new licence from FDA
November 7, 2011Sales and Marketing
The FDA has approved Bayer/J&J’s Xarelto once-daily pill for stroke prevention in patients with an abnormal heart rhythm. The US …
Ranbaxy to collaborate with Teva on generic Lipitor in US?
November 7, 2011Manufacturing and Production, Sales and Marketing Lipitor, Pfizer, Ranbaxy, Teva
Israeli drugmaker Teva Pharmaceutical could get an unexpected boost from an earlier-than-expected launch of its generic version of Pfizer’s cholesterol …
Steve Hobbs joins Apodi senior management team
November 4, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Steve Hobbs has joined Apodi’s senior management team as director of business and account development. Steve has over 30 years …
Graham Higson joins NDA Group to lead Regulatory and HTA Advisory Board
November 4, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NDA
GE Healthcare and ex AstraZeneca Head of Global Regulatory Affairs, Graham Higson, will join NDA Group in January 2012 to …
FDA boasts better approval rates than Europe
November 4, 2011Medical Communications, Research and Development FDA, approvals
US regulator the FDA has approved more drugs and at a faster rate than its European counterpart.A new report by …
GSK, Pfizer joint venture to start manufacturing ops in Russia
November 4, 2011Manufacturing and Production GSK, Pfizer, manufacturing
A joint venture set up by GlaxoSmithKline and Pfizer is planning to start manufacturing in Russia thanks to a partnership …
Ketchum wins International Consultancy of the Year award
November 3, 2011Medical Communications Ketchum, Ketchum Pleon, PR
Ketchum Pleon has accepted the International Consultancy of the Year award on behalf of the global firm Ketchum at the …
GSK pays $3 billion to settle US marketing probe
November 3, 2011Sales and Marketing GSK, compliance, federal investigation
GlaxoSmithKline has agreed to pay $3 billion to settle US government investigations into the sales and marketing of diabetes drug …
Synergy Vision hires Caroline Loder and Natalie Ferguson
November 3, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Synergy Vision
Synergy Vision, the London-based medical communications agency, has hired Caroline Loder as a senior medical writer and Natalie Ferguson as a …
Teva sees modest growth as US sales fall
November 3, 2011Business Services, Sales and Marketing Teva, generics
Sales growth at Teva was modest in Q3, rising 2% to $4.34 billion, with growth predominately coming from branded drugs.This …
Doctors decry cost-cutting in HIV treatment
November 2, 2011Sales and Marketing HIV, NHS, Reyataz
Doctors in London are opposing a decision to switch HIV patients to a cheaper drug, saying it could harm patients. …
Richard Daniell appointed as managing director of Teva UK
November 2, 2011Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Teva Pharmaceutical
Richard Daniell has been appointed as managing director for Teva UK, and will be responsible for all Teva’s commercial activities …
Sanofi to become world’s biggest drug maker
November 2, 2011Medical Communications, Research and Development, Sales and Marketing Pfizer, Sanofi, top 10
Sanofi will replace Pfizer as the world’s biggest drug maker by revenue next year, according to new forecasts. Pfizer’s nine-year …
Prevnar and Lyrica lift Pfizer results
November 1, 2011Research and Development, Sales and Marketing Lipitor, Lyrica, Pfizer, Prevnar, patent expiry
Strong sales of Lyrica and its Prevnar vaccines coupled with favourable exchange rates have helped Pfizer deliver a strong quarter. …
Lundbeck appoints two new R&D vice presidents
November 1, 2011Research and Development Lundbeck, R&D
Lundbeck has appointed Jens Peter Balling and Iman Barilero as vice presidents of its research and development organisation. The new …
Obama takes action to curb medicine shortages
November 1, 2011Manufacturing and Production, Research and Development, Sales and Marketing FDA, Obama, drugs
US President Barack Obama has ordered the FDA and Department of Justice to take action to reduce and prevent medicine …
Lonza sees continued recovery in third quarter
November 1, 2011Manufacturing and Production, Sales and Marketing Lonza, Q3, manufacturing and production
Revenue growth at contract manufacturing organisation Lonza in the third quarter was once again undermined by the strength of the …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
